Literature DB >> 18787105

Tumor recovery by angiogenic switch from sprouting to intussusceptive angiogenesis after treatment with PTK787/ZK222584 or ionizing radiation.

Ruslan Hlushchuk1, Oliver Riesterer, Oliver Baum, Jeanette Wood, Guenther Gruber, Martin Pruschy, Valentin Djonov.   

Abstract

Inhibitors of angiogenesis and radiation induce compensatory changes in the tumor vasculature both during and after treatment cessation. To assess the responses to irradiation and vascular endothelial growth factor-receptor tyrosine kinase inhibition (by the vascular endothelial growth factor tyrosine kinase inhibitor PTK787/ZK222854), mammary carcinoma allografts were investigated by vascular casting; electron, light, and confocal microscopy; and immunoblotting. Irradiation and anti-angiogenic therapy had similar effects on the tumor vasculature. Both treatments reduced tumor vascularization, particularly in the tumor medulla. After cessation of therapy, the tumor vasculature expanded predominantly by intussusception with a plexus composed of enlarged sinusoidal-like vessels containing multiple transluminal tissue pillars. Tumor revascularization originated from preserved alpha-smooth muscle actin-positive vessels in the tumor cortex. Quantification revealed that recovery was characterized by an angiogenic switch from sprouting to intussusception. Up-regulated alpha-smooth muscle actin-expression during recovery reflected the recruitment of alpha-smooth muscle actin-positive cells for intussusception as part of the angio-adaptive mechanism. Tumor recovery was associated with a dramatic decrease (by 30% to 40%) in the intratumoral microvascular density, probably as a result of intussusceptive pruning and, surprisingly, with only a minimal reduction of the total microvascular (exchange) area. Therefore, the vascular supply to the tumor was not severely compromised, as demonstrated by hypoxia-inducible factor-1alpha expression. Both irradiation and anti-angiogenic therapy cause a switch from sprouting to intussusceptive angiogenesis, representing an escape mechanism and accounting for the development of resistance, as well as rapid recovery, after cessation of therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18787105      PMCID: PMC2543084          DOI: 10.2353/ajpath.2008.071131

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  49 in total

Review 1.  Angiogenesis as a therapeutic target.

Authors:  Napoleone Ferrara; Robert S Kerbel
Journal:  Nature       Date:  2005-12-15       Impact factor: 49.962

2.  Antiangiogenic therapy: a universal chemosensitization strategy for cancer?

Authors:  Robert S Kerbel
Journal:  Science       Date:  2006-05-26       Impact factor: 47.728

Review 3.  Bevacizumab combined with standard fluoropyrimidine-based chemotherapy regimens to treat colorectal cancer.

Authors:  Herbert Hurwitz; Fairooz Kabbinavar
Journal:  Oncology       Date:  2005-11-21       Impact factor: 2.935

4.  Rapid vascular regrowth in tumors after reversal of VEGF inhibition.

Authors:  Michael R Mancuso; Rachel Davis; Scott M Norberg; Shaun O'Brien; Barbara Sennino; Tsutomu Nakahara; Virginia J Yao; Tetsuichiro Inai; Peter Brooks; Bruce Freimark; David R Shalinsky; Dana D Hu-Lowe; Donald M McDonald
Journal:  J Clin Invest       Date:  2006-10       Impact factor: 14.808

5.  Microvascular endowment in the developing chicken embryo lung.

Authors:  A N Makanya; R Hlushchuk; O Baum; N Velinov; M Ochs; V Djonov
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-01-23       Impact factor: 5.464

6.  KRN951, a highly potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, has antitumor activities and affects functional vascular properties.

Authors:  Kazuhide Nakamura; Eri Taguchi; Toru Miura; Atsushi Yamamoto; Kazumi Takahashi; Francis Bichat; Nicolas Guilbaud; Kazumasa Hasegawa; Kazuo Kubo; Yasunari Fujiwara; Rika Suzuki; Kinya Kubo; Masabumi Shibuya; Toshiyuki Isae
Journal:  Cancer Res       Date:  2006-09-15       Impact factor: 12.701

7.  Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinoma.

Authors:  David Semela; Anne-Christine Piguet; Mirjam Kolev; Karin Schmitter; Ruslan Hlushchuk; Valentin Djonov; Christoforos Stoupis; Jean-François Dufour
Journal:  J Hepatol       Date:  2007-01-17       Impact factor: 25.083

8.  Ionizing radiation antagonizes tumor hypoxia induced by antiangiogenic treatment.

Authors:  Oliver Riesterer; Michael Honer; Wolfram Jochum; Christoph Oehler; Simon Ametamey; Martin Pruschy
Journal:  Clin Cancer Res       Date:  2006-06-01       Impact factor: 12.531

9.  Antiangiogenesis and drug delivery to tumors: bench to bedside and back.

Authors:  Dan G Duda
Journal:  Cancer Res       Date:  2006-04-15       Impact factor: 12.701

Review 10.  Bevacizumab, a humanized anti-angiogenic monoclonal antibody for the treatment of colorectal cancer.

Authors:  I Krämer; H-P Lipp
Journal:  J Clin Pharm Ther       Date:  2007-02       Impact factor: 2.512

View more
  32 in total

Review 1.  The mammary gland vasculature revisited.

Authors:  Anne-Catherine Andres; Valentin Djonov
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-08-14       Impact factor: 2.673

2.  Biomechanical regulation of blood vessel growth during tissue vascularization.

Authors:  Witold W Kilarski; Branka Samolov; Ludvig Petersson; Anders Kvanta; Pär Gerwins
Journal:  Nat Med       Date:  2009-06       Impact factor: 53.440

3.  Intussusceptive microvascular growth in human glioma.

Authors:  Beatrice Nico; Enrico Crivellato; Diego Guidolin; Tiziana Annese; Vito Longo; Nicoletta Finato; Angelo Vacca; Domenico Ribatti
Journal:  Clin Exp Med       Date:  2009-10-31       Impact factor: 3.984

Review 4.  Intussusceptive angiogenesis and its counterpart intussusceptive lymphangiogenesis.

Authors:  L Díaz-Flores; R Gutiérrez; S Gayoso; M P García; M González-Gómez; L Díaz-Flores; R Sánchez; J L Carrasco; J F Madrid
Journal:  Histol Histopathol       Date:  2020-04-24       Impact factor: 2.303

Review 5.  Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?

Authors:  Rakesh R Ramjiawan; Arjan W Griffioen; Dan G Duda
Journal:  Angiogenesis       Date:  2017-03-30       Impact factor: 9.596

6.  A new mechanism for pillar formation during tumor-induced intussusceptive angiogenesis: inverse sprouting.

Authors:  Sándor Paku; Katalin Dezso; Edina Bugyik; József Tóvári; József Tímár; Péter Nagy; Viktoria Laszlo; Walter Klepetko; Balázs Döme
Journal:  Am J Pathol       Date:  2011-08-09       Impact factor: 4.307

7.  Radiation therapy primes tumors for nanotherapeutic delivery via macrophage-mediated vascular bursts.

Authors:  Miles A Miller; Ravi Chandra; Michael F Cuccarese; Christina Pfirschke; Camilla Engblom; Shawn Stapleton; Utsarga Adhikary; Rainer H Kohler; James F Mohan; Mikael J Pittet; Ralph Weissleder
Journal:  Sci Transl Med       Date:  2017-05-31       Impact factor: 17.956

Review 8.  Mouse models for studying angiogenesis and lymphangiogenesis in cancer.

Authors:  Lauri Eklund; Maija Bry; Kari Alitalo
Journal:  Mol Oncol       Date:  2013-03-05       Impact factor: 6.603

9.  Radiotherapy suppresses angiogenesis in mice through TGF-betaRI/ALK5-dependent inhibition of endothelial cell sprouting.

Authors:  Natsuko Imaizumi; Yan Monnier; Monika Hegi; René-Olivier Mirimanoff; Curzio Rüegg
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

10.  Arterio-arterial malformation between a high origin radial artery and brachial artery within the cubital fossa - its clinical and embryological significance: a case report.

Authors:  Salvatore Docimo; Dellene E Kornitsky; Robert V Hill; David E Elkowitz
Journal:  Cases J       Date:  2009-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.